Qube Research & Technologies Ltd - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 1 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$4,000
-60.0%
17,548
-11.5%
0.00%–
Q2 2022$10,000
-96.7%
19,831
-72.8%
0.00%
-100.0%
Q4 2021$304,000–72,903–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders